RecruitingNCT05116514
About this title
Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode.
Read the official source — NCT05116514Official study titleEvaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode. Randomized, Open-label, Multicenter Controlled Study With Blinded Evaluation.
Multiple locations, including MontpellierSchizophreniaInterventional studyAges 16–30
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
RecruitingNCT07621549
In New Taipei CitySchizophreniaDevice studyAges 18–65
- Countries
- Taiwan
- Sponsor
- Far Eastern Memorial Hospital
RecruitingNCT05783063
Official study titleEffects of Intermittent Theta Burst Stimulation (iTBS) on Increased Appetite Induced by Antipsychotics in Patients With Schizophrenia
In DaliSchizophreniaDevice studyAges 18–40
- Countries
- China
- Sponsor
- Central South University
RecruitingNCT06174116
Official study titleMetabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
In WorcesterSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of Massachusetts, Worcester
RecruitingNCT06340789
Official study titleFunctional Connectivity and Associated Neuropeptides Variations in Treatment Resistant Schizophrenia Patients: Treatment Efficacy of add-on Sodium Benzoate
In Chiayi CitySchizophreniaMedication studyAges 20–55
- Countries
- Taiwan
- Sponsor
- National Cheng-Kung University Hospital
RecruitingNCT07469384
Official study titleSensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation
In OrangeburgSchizophreniaDevice studyAges 18–55
- Countries
- United States
- Sponsor
- Nathan Kline Institute for Psychiatric Research
RecruitingNCT05340348
About this title
Patientheque in Patients With a Psychosis
Read the official source — NCT05340348Official study titleFormation of a Patientheque in Patients With a Beginner Psychosis
In BrestSchizophreniaInterventional studyAges 15–30
- Countries
- France
- Sponsor
- University Hospital, Brest
RecruitingNCT07460453
Official study titleStudy of Life Challenges, Personality, and Emotional Experiences
In BloomingtonSchizophreniaBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Indiana University
RecruitingNCT05704582
Official study titleA Randomized Controlled Trial Comparing Avatar Intervention to an Addiction Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
In MontrealSchizophrenia, AddictionInterventional studyAges 18+
- Countries
- Canada
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
RecruitingNCT07686263
Official study titleA Phase 3 Double-blind, Placebo-controlled Randomized Withdrawal Maintenance Trial of KarXT Treatment in Participants With Schizophrenia
Multiple locations, including BentonvilleSchizophreniaMedication studyAges 18–65
- Countries
- United States, Argentina, Bulgaria, + 4 others
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
RecruitingNCT05398120
About this title
Skills Group for Youth at Clinical High-Risk for Psychosis
Read the official source — NCT05398120Official study titleTesting the Feasibility of a Skills Group for Adolescents and Young Adults at Clinical High-risk for Psychosis
In PittsburghSchizophreniaBehavioural studyAges 13–18
- Countries
- United States
- Sponsor
- University of Pittsburgh
